Companies: 10,795·Total market cap: $144.5T
Novartis AG

Novartis AG

NVSNYSEHealthcare● Active
$149.16
+$0.76(+0.51%)
Market Cap$284.6B
P/E Ratio
52W High$170.46
52W Low$112.34

Novartis AG (NVS) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

nvs · stock forecast · 25 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 25 Wall Street analysts in the past 3 months

SellBuy

Hold

25 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
6
Hold
17
Sell
2
Strong Sell
0
Total: 25 · Buy rate: 24.0%

12-Month Price Target

High

$170

Consensus

$141

-5.5% upside

Low

$112

Median: $141 · Last Close: $149.16

The Novartis AG (NVS) analyst consensus is Hold, based on ratings from 25 Wall Street analysts over the past 3 months. The average 12-month NVS price target is $141.00, representing -5.5% upside from the current price of $149.16.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $141 (-5.5%)

Consensus Target

$141.00

-5.5% upside

High Target

$170

14.0%

Low Target

$112

-24.9%

Current Price

$149.16

as of today

Based on analyst price targets, the NVS stock price prediction for the next 12 months ranges from $112 to $170. The consensus NVS price forecast of $141.00 implies -5.5% upside from the current price of $149.16.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$147.241.28%

1-day model range: $146.86–$147.63. Peak: $147.63 (-1.28%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$203+35.8%
2028$250+67.4%
2029$287+92.7%
2030$316+111.6%
2031+125.1%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BULLISH

Based on 14 technical indicators

64%7%29%
9Buy
1Neutral
4Sell
RSI (14)52.8Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · NVS · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$146.08BUY
MA 10$148.59BUY
MA 20$148.73BUY
MA 50$149.28SELL
MA 100$152.28SELL
MA 200$141.18BUY
Current $NVS · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$147.60BUY
EMA 10$147.97BUY
EMA 20$148.36BUY
EMA 50$149.27SELL
EMA 100$148.01BUY
EMA 200$141.55BUY
Current $NVS · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Morgan Stanley2026-03-26
Maintains
OverweightOverweight
Barclays2026-01-06
Upgrade ↑
UnderweightEqual Weight
JP Morgan2025-12-08
Upgrade ↑
NeutralOverweight
Goldman Sachs2025-09-12
Downgrade ↓
NeutralSell
UBS2025-02-13
Downgrade ↓
BuyNeutral
Erste Group2024-11-19
Downgrade ↓
BuyHold
BMO Capital2024-10-30
Maintains
Market PerformMarket Perform
B of A Securities2024-09-11
Downgrade ↓
BuyNeutral
Goldman Sachs2024-09-05
Downgrade ↓
BuyNeutral
Jefferies2024-09-03
Downgrade ↓
BuyHold

Wall Street analysts have recently issued updated ratings on Novartis AG (NVS) stock. Of the recent 65 rating actions, 26 were upgrades and 32 were downgrades. 25 analysts currently cover NVS.

Analyst Recommendation Trends

Buy ratings01↑ +1
Hold ratings101
Sell ratings00

NVS analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 1 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$56.8B

↓ 11.4% YoY

Revenue Next Year

$60.2B

↑ 6.1% YoY

EPS This Year

$8.75

EPS Next Year

$9.75

↑ 11.5% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast NVS EPS of $8.75 for the current fiscal year, based on estimates from 7 analysts. The NVS revenue forecast is $56.8B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The NVS stock forecast is supported by two independent data sources: analyst consensus ratings from 25 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus NVS price target is $141.00 (-5.5% upside), with an analyst consensus of Hold.

The NVS short-term stock prediction for tomorrow is $147.24 (-1.28%). The NVS stock price prediction for 2027 estimates an average of $203. The NVS stock prediction for 2030 projects a range of $307–$325.

Novartis AG trades on NYSE under the ticker NVS. The NVS stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 24% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

NVS forecast · 8 questions

According to 25 Wall Street analysts, the average 12-month NVS price target is $141.00, with a high forecast of $170.00 and a low of $112.00. The median price target is shown in the chart above when available. This implies -5.5% potential upside from the current price of $149.16.

NVS price targetWhat is NVS price targetNVS analyst price targetNVS 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.